Targeting SERPINE1 with Esculetin for Migraine Management: Computational Insights and in-vitro Validation
Kishore Kumar V, Ganesh H & Natarajan P · Journal of Pharmaceutical Research International · 2025
Migraine is a multifactorial neurovascular disorder involving aberrant neuronal excitability, vascular dysregulation, and neuroinflammation. Current therapies often provide incomplete relief and may cause adverse effects, highlighting the need for safer, multi-target intervention...
Open access
Research Article
10.9734/jpri/2025/v37i107754